Rejuvel Bio-Sciences, Inc.

OTCPK:NUUU Stock Report

Market Cap: US$8.8k

Rejuvel Bio-Sciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Charles Scimeca

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure14.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure7.8yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Charles Scimeca (79 yo)

14.6yrs

Tenure

US$120,000

Compensation

Mr. Charles J. Scimeca is the Chief Executive Officer and Director of Rejuvel Bio-Sciences, Inc. He served as the President, Secretary and Treasurer of Rejuvel Bio-Sciences, Inc. (also known as Technology...

Board Members

NamePositionTenureCompensationOwnership
Charles Scimeca
CEO & Director14.6yrsUS$120.00kno data
Matthew Cohen
CFO & Director7.8yrsno datano data
Joseph Pavlik
Director7.8yrsno datano data
Robert Dowdell
Member of Scientific Advisory Boardno datano datano data
Michelle Lewis
Member of Scientific Advisory Boardno datano datano data
David Mastropietro
Member of Scientific Advisory Boardno datano datano data
Malav Trivedi
Member of Scientific Advisory Boardno datano datano data

7.8yrs

Average Tenure

66yo

Average Age

Experienced Board: NUUU's board of directors are considered experienced (7.8 years average tenure).